These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 8622893)

  • 1. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
    Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD
    Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activity.
    Choi S; Park S
    Oncogene; 1999 Sep; 18(39):5413-22. PubMed ID: 10498895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region.
    Zisch AH; Kalo MS; Chong LD; Pasquale EB
    Oncogene; 1998 May; 16(20):2657-70. PubMed ID: 9632142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions.
    Hock B; Böhme B; Karn T; Feller S; Rübsamen-Waigmann H; Strebhardt K
    Oncogene; 1998 Jul; 17(2):255-60. PubMed ID: 9674711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.
    Holland SJ; Gale NW; Gish GD; Roth RA; Songyang Z; Cantley LC; Henkemeyer M; Yancopoulos GD; Pawson T
    EMBO J; 1997 Jul; 16(13):3877-88. PubMed ID: 9233798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
    Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands.
    Holland SJ; Gale NW; Mbamalu G; Yancopoulos GD; Henkemeyer M; Pawson T
    Nature; 1996 Oct; 383(6602):722-5. PubMed ID: 8878483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
    Yu HH; Zisch AH; Dodelet VC; Pasquale EB
    Oncogene; 2001 Jul; 20(30):3995-4006. PubMed ID: 11494128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.
    Zisch AH; Pazzagli C; Freeman AL; Schneller M; Hadman M; Smith JW; Ruoslahti E; Pasquale EB
    Oncogene; 2000 Jan; 19(2):177-87. PubMed ID: 10644995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
    Rodrigues GA; Park M
    Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative modes of tyrosyl phosphopeptide binding to a Src family SH2 domain: implications for regulation of tyrosine kinase activity.
    Ladbury JE; Hensmann M; Panayotou G; Campbell ID
    Biochemistry; 1996 Aug; 35(34):11062-9. PubMed ID: 8780508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3).
    Davis TL; Walker JR; Loppnau P; Butler-Cole C; Allali-Hassani A; Dhe-Paganon S
    Structure; 2008 Jun; 16(6):873-84. PubMed ID: 18547520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of interactions between epidermal growth factor receptor and SH2 domain proteins.
    Sierke SL; Longo GM; Koland JG
    Biochem Biophys Res Commun; 1993 Feb; 191(1):45-54. PubMed ID: 7680558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of p59fyn kinase with the dynein light chain, Tctex-1, and colocalization during cytokinesis.
    Campbell KS; Cooper S; Dessing M; Yates S; Buder A
    J Immunol; 1998 Aug; 161(4):1728-37. PubMed ID: 9712037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRC-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin.
    Li H; Lemay S; Aoudjit L; Kawachi H; Takano T
    J Am Soc Nephrol; 2004 Dec; 15(12):3006-15. PubMed ID: 15579503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.